Oriola-KD Corporation Press Release 9 February 2016 at 9.30 a.m.

Oriola-KD has completed the acquisition of Svensk Dos

Oriola-KD has completed the acquisition of Svensk Dos, announced on 3 December 2015, according to plan. Svensk Dos will be reported as part of Oriola-KD's Healthcare segment.

Svensk Dos is specialized in dose dispensing of pharmaceuticals. Svensk Dos provides dose dispensed medicines to 24,000 people via extradition locations and nursing homes in the region of Skåne and direct to the Swedish Prison and Probation Service all over Sweden. In 2014, the net sales of Svensk Dos were approximately MEUR 25 and estimated market share was 13 %. Svensk Dos has also been awarded the contract for dose dispensing of pharmaceuticals to 42,500 patients in the so called Sjuklövern cluster (Gävleborg, Västmanland, Sörmland, Uppsala, Värmland, Dalarna och Örebro). The Sjuklövern contract is currently under appeal. Svensk Dos has approximately 60 employees and is based in Uppsala.

Oriola-KD Corporation

Eero Hautaniemi
President and CEO

Further information:

Eero Hautaniemi
President and CEO
Tel. +358 (0)10 429 2109
e-mail: eero.hautaniemi@oriola-kd.com

Thomas Gawell
Vice President, Healthcare Business
Tel. + 46 31 88 70 42
e-mail: thomas.gawell@oriola.com

Oriola-KD Oyj issued this content on 09 February 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 09 February 2016 07:36:20 UTC

Original Document: http://www.oriola-kd.com/link/2cdfd4e98f7b416cb7985c2d11d53a1e.aspx?epslanguage=en